doi: 10.3389/fcdhc.2025.1590530 Received 09 March 2025 Accepted 18 June 2025 Published 10 July 2025 Volume 6 - 2025 Edited by Angelo Maria Patti, University of Palermo, Italy Reviewed by Anapaula Sommer Vinagre, Federal University of Rio Grande do Sul, Brazil Jun Eguchi, Okayama University, Japan Updates Copyright 2025 Hammad, Zafar, Ullah, Faisal, Iftikhar, Waheed, Muzaffar, Ahmed, Ashraf, Zahid, Akhtar and Mahmmoud Fadelallah Eljack
After my diagnosis, my OB/GYN recommended that I see an endocrinologist and try to lose weight
So far only one brand of semaglutidean injectable drug called Wegovyis FDA-approved for weight loss
From a purely pharmacological perspective, abruptly stopping Rybelsus is generally considered physically safe for most patientsthere is no official link between sudden discontinuation and acute medical emergencies or dangerous withdrawal reactions